1352079-19-6

Basic information

• Product Name: 4,4,4-trifluoro-1-{4-[3-(4-hydroxyphenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}butan-1-one
• CAS NO: 1352079-19-6
• Molecular Weight: 369.343
• Mol File: 1352079-19-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4,4,4-trifluoro-1-{4-[3-(4-hydroxyphenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}butan-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 4,4,4-trifluoro-1-{4-[3-(4-hydroxyphenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}butan-1-one(1352079-19-6)
• EPA Substance Registry System: 4,4,4-trifluoro-1-{4-[3-(4-hydroxyphenyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}butan-1-one(1352079-19-6)

Safety Data

• Hazardous Substances Data: 1352079-19-6(Hazardous Substances Data)

Upstream product

• 406-93-9 4,4,4-trifluorobutyric acid 

Relevant articles and documents

COMPOUNDS HAVING AN ETHR INHIBITING ACTIVITY - USE OF SAID COMPOUNDS AS DRUGS - PHARMACEUTICAL COMPOSITION AND PRODUCT CONTAINING SAID COMPOUNDS

The present invention relates to compounds of Formula (I), wherein R1 is chosen among the following radicals : (II); (III); (IV), (V), (VI) (VII) and n= 1 or 2 and m=1 or 2 with the proviso that m=2 when R1 is (VIII). The present invention also relates to the use thereof as drugs, more particularly in the treatment of mycobacterial infections and more particularly in the treatment of tuberculosis.